|

The Immune Assessment of PD-1 Antibody Therapy in Tumor

RECRUITINGSponsored by Quanli Gao
Actively Recruiting
SponsorQuanli Gao
Started2021-07-01
Est. completion2027-11-13
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06693440

Summary

This retrospective study will leverage previous immune function monitoring results in conjunction with clinical case data at this medical center.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age ≥18 years.
2. Pathologically confirmed malignant tumors.
3. Complete medical records.
4. Assessable immune function test data.

Exclusion Criteria:

1. Age \<18 years.
2. No confirmed tumor pathology.
3. Untraceable medical records.
4. Non-assessable immune function tests.

Conditions3

Adverse EventCancerEfficacy, Team

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.